| Company/Division name | AbbVie |
| Parent company | AbbVie |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 734 |
| Year reshoring announced: | 2026 |
| Year reshoring implemented or to be implemented: | 2028 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 1400 |
| City reshored to: | Durham |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Pharmaceutical drugs |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Higher productivity, Manufacturing/engineering joint innovation (R&D) |
